SCHEMBL279783

SCHEMBL279783

C1=CN=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23221363 0.84
Furan SCHEMBL25381169 0.82 MAPK1 (0.38)
SCHEMBL1985537 0.80
SCHEMBL19432176 0.70
SCHEMBL7091762 0.67
SCHEMBL7091760 0.67
SCHEMBL179255 0.67
SCHEMBL9905529 0.64
SCHEMBL1423736 0.64
SCHEMBL4563756 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 618 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110418790-A Imidazo pyrroles's ketone compound as p53-MDM2 inhibitor LUOXIN BIOTECHNOLOGY SHANGHAI CO LTD 2019-11-05 CN claimed
CN-105517996-B Therapeutical active compound and its application method 安吉奥斯医药品有限公司 2019-03-26 CN claimed
CN-107001236-A The purification process and 1,5 pentanediamines of a kind of 1,5 pentanediamine 上海凯赛生物技术研发中心有限公司 2017-08-01 CN claimed
EP-3157919-A1 BET-PROTEIN INHIBITING 3,4-DIHYDROPYRIDO[2,3-B]PYRAZINONES WITH META-SUBSTITUTED AROMATIC AMINO- OR ETHER GROUPS Bayer Pharma Aktiengesellschaft (DE) 2017-04-26 EP claimed
CN-105518001-A MODIFIED BET-PROTEIN-INHIBITING DIHYDROQUINOXALINONES AND DIHYDROPYRIDOPYRAZINONES Bayer Pharma AG 2016-04-20 CN claimed
CN-105481857-A Alpha-pinene derivative and preparation method and application thereof UNIV GUANGDONG PHARM 2016-04-13 CN claimed
WO-2015193219-A1 BET-PROTEIN INHIBITING 3,4-DIHYDROPYRIDO[2,3-B]PYRAZINONES WITH META-SUBSTITUTED AROMATIC AMINO- OR ETHER GROUPS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-12-23 WO claimed
CN-105101970-A Beta-lactamase inhibitors VENATORX PHARMACEUTICALS INC 2015-11-25 CN claimed
CN-102603615-A Intermediates of 2-acetonyl-3-methoxy piperidine and preparation method of 2-acetonyl-3-methoxy piperidine OCEAN UNIV CHINA 2012-07-25 CN claimed
EP-2270006-A1 Pyridazine derivatives useful as vanilloid receptor ligands Amgen, Inc (US) 2011-01-05 EP claimed
EP-0133612-B1 SUBSTITUTED 2,6-SUBSTITUTED PYRIDINE COMPOUNDS MONSANTO COMPANY (US) 1991-02-27 EP claimed
EP-0221720-B1 DIHYDROPYRIDINES Pfizer Limited (GB) 1990-06-27 EP claimed
EP-0118120-B1 1,4-DIHYDROPYRIDINE COMPOUND NIKKEN CHEMICALS CO., LTD. (JP) 1989-06-14 EP claimed
EP-0110073-B1 PROCESS FOR THE PREPARATION OF TETRAHYDROPYRIDINES BAYER AG (DE) 1987-07-01 EP claimed
EP-0110259-B1 1,4-DIHYDROPYRIDINES, PROCESSES FOR THEIR PREPARATION AND THEIR USE IN MEDICINES BAYER AG (DE) 1986-12-17 EP claimed
EP-0088274-B1 1,4-DIHYDROPYRIDINES, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION AS PHARMACEUTICAL PREPARATIONS BAYER AG (DE) 1986-09-03 EP claimed
EP-0133612-A2 Substituted 2,6-substituted pyridine compounds MONSANTO COMPANY (US) 1985-02-27 EP claimed
EP-0125803-A2 Pharmaceutically active dihydropyridines FISONS plc (GB) 1984-11-21 EP claimed
EP-0012180-B1 1,4-DIHYDROPYRIDINE COMPOUNDS, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS AND PREPARATION OF THESE COMPOSITIONS BAYER AG (DE) 1982-06-23 EP claimed
EP-0002208-B1 NITRO 1,4-DIHYDROPYRIDINES, MEDICAMENTS CONTAINING THEM AND THEIR MANUFACTURE BAYER AG (DE) 1981-03-11 EP claimed